European Society of Breast Cancer Specialists EJC online - The official journal of EUSOMA Improving Breast Cancer Care in Europa
ABOUT EUSOMAGUIDELINES & PUBLICATIONSBREAST UNITSNEWSEVENTSBECOME A MEMBER
   Search            Home       Site map       Links       FAQ       Contact Us            

 

 


Other Guidelines

Guidelines on endocrine therapy of breast cancer

Guidelines Writing Committee Members

R.W. Blamey (Chairman, and Vice President of EUSOMA), Nottingham, UK
H Bartelink, Amsterdam, Netherlands
M. Baum, London, UK
F.Boccardo, Genoa, Italy
L.Cataliotti, (President of EUSOMA), Florence, Italy
H Cortes Funes, Madrid, Spain
J.C.J.M.de Haes, Amsterdam, Netherlands
L.Fallowfield, Sussex, UK
A.Goldhirsch, Milan, Italy
M.Greco (Hon. Secretary of EUSOMA), Milan, Italy
K. Holli, Tampere, Finland
R. Jakesz, Vienna, Austria
J. Jaskiewicz, Gdansk, Poland
M.Welnika-Jaskiewicz, Gdansk, Poland
W. Jonat, Kiel, Germany
M.Kaufmann, Frankfurt, Germany
M. Kerin, Dublin, Ireland
J. Klijn, Rotterdam, The Netherlands
P. E. Lonning, Bergen, Norway
W. Miller, Edinburgh, UK
H. Mouridsen, Copenhagen, Denmark
T. Nagykalnai, Budapest, Hungary
P. Neven, Brussels, Belgium
R. Nicholson, Cardiff, UK
M. Piccart, Brussels, Belgium
C. Rose, Lund, Sweden
E. Rutgers, Amsterdam, The Netherlands
L. Rutqvist, Stockholm, Sweden
B. J.K.Thurlimann, St Gallen, Switzerland

Facilitators: Graham Denton Associates Ltd.

The provisional Guidelines were distributed at the 7th Nottingham International Breast Cancer Meeting. Comments were invited an were received from R Sainsbury (UK), R Leake (UK), J Dewar (UK), C Elston (UK) and J Bergh (Sweden).

Production of the series of EUSOMA Guidelines on aspects of breast cancer has been supported with the aid of an educational grant to EUSOMA from AstraZeneca plc.

 

Back Next

Please use this address to send us any comments you want to make on the guidelines - we welcome your feedback: information@eusoma.org

 

     
 
Index
  Introduction
  For which tumor types should endocrine therapy be restricted?
  Endocrine therapy in primary breast cancer
  Endocrine therapy for advanced breast cancer
  Other indications for endocrine therapy
  Quality of life issues in endocrine therapy
  Guidelines Writing Committee Members

 

 

| Webmaster | Privacy | Disclaimer | Credits |